VanEck Associates
GMO

VanEck Associates’s General Moly, Inc. GMO Stock Holding History

VanEck Associates’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,605,999
Closed -$1.2M – 822
2014
Q3 		$1.2M Sell
1,605,999
-44,843
-3% -$43.9K 0.01% 396
2014
Q2 		$1.9M Sell
1,650,842
-71,804
-4% -$74.9K 0.01% 353
2014
Q1 		$1.71M Sell
1,722,646
-153,234
-8% -$186K 0.01% 331
2013
Q4 		$2.51M Sell
1,875,880
-15,483
-0.8% -$22.2K 0.01% 299
2013
Q3 		$3.12M Buy
1,891,363
+427,306
+29% +$770K 0.02% 267
2013
Q2 		$2.74M Buy
+1,464,057
New +$2.88M 0.01% 273

Other funds holding GMO

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Fernwood Investment Management Quincy, Massachusetts $288M AUM 33.54% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VanEck Associates's GMO Position: Q4 2014 in Review

VanEck Associates sold out of General Moly, Inc. (GMO) in Q4 2014, closing a stake of 1,605,999 shares — an estimated $1.2M sold.

VanEck Associates first reported a position in GMO in Q2 2013 and held it in 6 quarters. The position peaked at $3.12M in Q3 2013. 48 funds tracked by Wall St. Rank hold GMO as of Q4 2014.

  • VanEck Associates reported no remaining General Moly, Inc. position as of Q4 2014 after selling out during the quarter.
  • VanEck Associates sold 1,605,999 General Moly, Inc. shares in Q4 2014, an estimated $1.2M.
  • VanEck Associates first reported a position in General Moly, Inc. in Q2 2013 and held it in 6 quarters.
  • VanEck Associates's General Moly, Inc. position peaked at $3.12M in Q3 2013.
  • 48 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2014.

Based on VanEck Associates's 13F filing for Q4 2014, filed 13 Feb 2015.